DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Zhang YL, Zhou C, Li XF. et al.
Beinaglutide showed significant weight-loss benefit and effective glycaemic
control for the treatment of type 2 diabetes in a real-world setting: A
3–month, multicentre, observational, retrospective, open-label
study.
Obes Sci Pract 2019;
5: 366-375
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.